Andri Signorell

1.6k total citations · 1 hit paper
32 papers, 1.1k citations indexed

About

Andri Signorell is a scholar working on General Health Professions, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Andri Signorell has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in General Health Professions, 10 papers in Public Health, Environmental and Occupational Health and 9 papers in Epidemiology. Recurrent topics in Andri Signorell's work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and Palliative Care and End-of-Life Issues (4 papers). Andri Signorell is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (5 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and Palliative Care and End-of-Life Issues (4 papers). Andri Signorell collaborates with scholars based in Switzerland, United States and Germany. Andri Signorell's co-authors include Oliver Reich, Roger M. Nitsch, Christoph Höck, Alessia Maddalena, Andreas Papassotiropoulos, M. Axel Wollmer, Johannes Streffer, Uwe Konietzko, Jay Tracy and Eva Moritz and has published in prestigious journals such as Neuron, PLoS ONE and Pain.

In The Last Decade

Andri Signorell

32 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibodies against β-Amyloid Slow Cognitive Decline in Alzheimer's Disease

2003 581 citations Christoph Höck, Uwe Konietzko et al. Neuron profile →

Peers

Countries citing papers authored by Andri Signorell

Since Specialization

Citations

This map shows the geographic impact of Andri Signorell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andri Signorell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andri Signorell more than expected).

Fields of papers citing papers by Andri Signorell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andri Signorell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andri Signorell. The network helps show where Andri Signorell may publish in the future.

Co-authorship network of co-authors of Andri Signorell

This figure shows the co-authorship network connecting the top 25 collaborators of Andri Signorell. A scholar is included among the top collaborators of Andri Signorell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andri Signorell. Andri Signorell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Childhood vaccination coverage and regional differences in Swiss birth cohorts 2012–2021: Are we on track? 2023 ·Vaccine ·Simeon Joel Zürcher, Andri Signorell, (unknown), Christoph Aebi, Carola A. Huber	3
2	Impact of the COVID-19 pandemic on antibiotic prescribing in high-prescribing primary care physicians in Switzerland 2023 ·Clinical Microbiology and Infection ·Soheila Aghlmandi, Florian S. Halbeisen, (unknown), Andri Signorell, (unknown), Ramon Saccilotto, Andreas F. Widmer, Andreas Zeller, Julia Bielicki, Heiner C. Bucher	1
3	Effect of Antibiotic Prescription Audit and Feedback on Antibiotic Prescribing in Primary Care 2023 ·JAMA Internal Medicine ·Soheila Aghlmandi, Florian S. Halbeisen, Ramon Saccilotto, (unknown), Andri Signorell, (unknown), Dominik Glinz, Giusi Moffa, Andreas Zeller, Andreas F. Widmer, Andreas Kronenberg, Julia Bielicki, Heiner C. Bucher	12
4	Secondary prevention of venous thromboembolism: Predictors and outcomes of guideline adherence in a long-term prospective cohort study 2022 ·Frontiers in Cardiovascular Medicine ·(unknown), (unknown), (unknown), (unknown), Andri Signorell, Carola A. Huber, Eva Blozik, Johanna A. Kremer Hovinga, Lucas M. Bachmann, Michael Nagler	3
5	Utilisation patterns and costs of lipid-lowering drugs in Switzerland 2013–2019 2021 ·Swiss Medical Weekly ·Daphne Reinau, Nadine Schur, (unknown), Eva Blozik, (unknown), Andri Signorell, Matthias Schwenkglenks, Christoph Meier	5
6	Potentially inappropriate medications and medication combinations before, during and after hospitalizations: an analysis of pathways and determinants in the Swiss healthcare setting 2021 ·BMC Health Services Research ·(unknown), Caroline Bähler, (unknown), Andri Signorell, Stefan Boes, Eva Blozik	1
7	Regional differences in healthcare costs at the end of life: an observational study using Swiss insurance claims data 2020 ·International Journal of Public Health ·Caroline Bähler, Roland Rapold, Andri Signorell, Oliver Reich, Radoslaw Panczak, Eva Blozik	4
8	Drug prescription patterns, polypharmacy and potentially inappropriate medication in Swiss nursing homes: a descriptive analysis based on claims data 2019 ·Swiss Medical Weekly ·(unknown), Daphne Reinau, Nadine Schur, Eva Blozik, (unknown), Andri Signorell, Christoph Meier, Matthias Schwenkglenks	23
9	Coverage rates and timeliness of nationally recommended vaccinations in Swiss preschool children: A descriptive analysis using claims data 2019 ·Vaccine ·(unknown), Daphne Reinau, Nadine Schur, Eva Blozik, (unknown), Andri Signorell, Ulrich Heininger, Matthias Schwenkglenks, Christoph Meier	14
10	Effects of managed care on the proportion of inappropriate elective diagnostic coronary angiographies in non-emergency patients in Switzerland: a retrospective cross-sectional analysis 2018 ·BMJ Open ·Corinne Chmiel, Oliver Reich, Andri Signorell, Stefan Neuner‐Jehle, Thomas Rosemann, Oliver Senn	1
11	Intensity of treatment in Swiss cancer patients at the end-of-life 2018 ·Cancer Management and Research ·Caroline Bähler, Andri Signorell, Eva Blozik, Oliver Reich	9
12	Glucocorticoids and the Risk of Peptic Ulcer Bleeding: Case–Control Analysis Based on Swiss Claims Data 2018 ·Drug Safety ·Daphne Reinau, Matthias Schwenkglenks, (unknown), Andri Signorell, Eva Blozik, Christoph Meier	15
13	Changes over time in prescription practices of pain medications in Switzerland between 2006 and 2013: an analysis of insurance claims 2017 ·BMC Health Services Research ·Maria M. Wertli, Oliver Reich, Andri Signorell, Jakob M. Burgstaller, Johann Steurer, Ulrike Held	40
14	Health Care Utilisation and Transitions between Health Care Settings in the Last 6 Months of Life in Switzerland 2016 ·PLoS ONE ·Caroline Bähler, Andri Signorell, Oliver Reich	17
15	How does hospitalization affect continuity of drug therapy: an exploratory study 2016 ·Therapeutics and Clinical Risk Management ·Eva Blozik, Andri Signorell, Oliver Reich	14
16	Health Care Utilization and Expenditures in Persons Receiving Social Assistance in 2012 Evidence From Switzerland 2014 ·Global Journal of Health Science ·Oliver Reich, (unknown), Andri Signorell, Eva Blozik	8
17	Improved prediction of medical expenditures and health care utilization using an updated chronic disease score and claims data 2013 ·Journal of Clinical Epidemiology ·Carola A. Huber, Sebastian Schneeweiß, Andri Signorell, Oliver Reich	41
18	Cerebrospinal Fluid Profile of Amyloid β Peptides in Patients with Alzheimer’s Disease Determined by Protein Biochip Technology 2004 ·Neurodegenerative Diseases ·Alessia Maddalena, Andreas Papassotiropoulos, Charo Gonzalez-Agosti, Andri Signorell, Thomas Hegi, Thomas Pasch, Roger M. Nitsch, Christoph Höck	67
19	Antibodies against β-Amyloid Slow Cognitive Decline in Alzheimer's Disease breakdown → 2003 ·Neuron ·Christoph Höck, Uwe Konietzko, Johannes Streffer, Jay Tracy, Andri Signorell, (unknown), Ulrike Lemke, Katharina Henke, Eva Moritz, (unknown), M. Axel Wollmer, Daniel Umbricht, Dominique J.‐F. de Quervain, M. Hofmann, Alessia Maddalena, Andreas Papassotiropoulos, Roger M. Nitsch	581
20	Treatment with the selective muscarinic ml agonist talsaclidine decreases cerebrospinal fluid levels of Aβ₄₂in patients with Alzheimer's disease 2003 ·Amyloid ·Christoph Höck, Alessia Maddalena, (unknown), F. Müller‐Spahn, Gerhard W. Eschweiler, (unknown), (unknown), Harald Hampel, (unknown), Wolfgang H. Oertel, M. Wienrich, Andri Signorell, Charo Gonzalez-Agosti, Roger M. Nitsch	82

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact